Spots Global Cancer Trial Database for flot
Every month we try and update this database with for flot cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions | NCT06313801 | Gastric Cancer | Docetaxel Oxaliplatin Calcium folinat... Fluorouracil Diagnostic lapa... dPIPAC ( The de... | 18 Years - 75 Years | Nizhny Novgorod Regional Clinical Oncology Center | |
| 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | NCT01216644 | Gastric Cancer | 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel Epirubicin Cisplatin 5-fluorouracil | 18 Years - | Krankenhaus Nordwest | |
| Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery | NCT05713838 | Esophagus Adeno... | Durvalumab FLOT mFOLFOX-6 Radiotherapy | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG | NCT04878783 | Gastric Cancer Adenocarcinoma ... | CT scan | 18 Years - | University of Roma La Sapienza | |
| Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer | NCT03647969 | Adenocarcinoma ... GastroEsophagea... | Nivolumab Ipilimumab mFOLFOX FLOT | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | NCT03636893 | Gastric Cancer Chemotherapy Ef... | FLOT Chemothera... SOX Chemotherap... | 18 Years - 80 Years | Ruijin Hospital | |
| Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma | NCT05504720 | Esophagogastric... | Pembrolizumab Trastuzumab FLOT | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) | NCT05733689 | Gastroesophagea... | ctDNA Blood Tes... FLOT FOLFOX FOLFIRI FOLFIRINOX PACLITAXEL with... DOCETAXEL and I... NIVOLUMAB (alon... PEMBROLIZUMAB (... | 18 Years - | University of California, Irvine | |
| Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery | NCT05713838 | Esophagus Adeno... | Durvalumab FLOT mFOLFOX-6 Radiotherapy | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Total Neoadjuvant Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer | NCT06028737 | Gastric Cancer Stomach Cancer GastroEsophagea... Gastric Adenoca... Gastroesophagea... Advanced Gastri... Gastric Neoplas... Stomach Neoplas... Gastrointestina... Advanced Gastro... Advanced Gastri... | Docetaxel Oxaliplatin Leucovorin Fluorouracil | 18 Years - 80 Years | Ukrainian Society of Clinical Oncology | |
| Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence | NCT04597294 | Gastric Cancer | FLOT + HIPEC + ... FLOT + Surgery | 18 Years - 75 Years | Jagiellonian University | |
| Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions | NCT06313801 | Gastric Cancer | Docetaxel Oxaliplatin Calcium folinat... Fluorouracil Diagnostic lapa... dPIPAC ( The de... | 18 Years - 75 Years | Nizhny Novgorod Regional Clinical Oncology Center | |
| Perioperative FLOT vs Adjuvant XELOX for CA Stomach | NCT05264896 | Cancer of Stoma... | 5-FU, Leucovori... XELOX | 18 Years - | Chinese University of Hong Kong | |
| Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery | NCT05713838 | Esophagus Adeno... | Durvalumab FLOT mFOLFOX-6 Radiotherapy | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma | NCT04393584 | Stomach Neoplas... Gastrointestina... Docetaxel Oxaliplatin Fluoruracil Irinotecan Hydr... | Irinotecan 5-FU Leucovorin Oxaliplatin Docetaxel | 18 Years - 70 Years | Blokhin's Russian Cancer Research Center | |
| Perioperative FLOT vs Adjuvant XELOX for CA Stomach | NCT05264896 | Cancer of Stoma... | 5-FU, Leucovori... XELOX | 18 Years - | Chinese University of Hong Kong | |
| Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions | NCT06313801 | Gastric Cancer | Docetaxel Oxaliplatin Calcium folinat... Fluorouracil Diagnostic lapa... dPIPAC ( The de... | 18 Years - 75 Years | Nizhny Novgorod Regional Clinical Oncology Center | |
| Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction | NCT02578368 | Gastric Cancer | 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel Trastuzumab sodium folinate Surgery | 18 Years - | Krankenhaus Nordwest | |
| Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric Cancer | NCT03399071 | Gastric Adenoca... Oesophageal Ade... | FLOT-A | 18 Years - | Royal Marsden NHS Foundation Trust | |
| 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | NCT01216644 | Gastric Cancer | 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel Epirubicin Cisplatin 5-fluorouracil | 18 Years - | Krankenhaus Nordwest | |
| Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial) | NCT05733689 | Gastroesophagea... | ctDNA Blood Tes... FLOT FOLFOX FOLFIRI FOLFIRINOX PACLITAXEL with... DOCETAXEL and I... NIVOLUMAB (alon... PEMBROLIZUMAB (... | 18 Years - | University of California, Irvine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
